Oligo CVV Production
ID: 75D301-24-Q-78627Type: Solicitation
Overview

Buyer

HEALTH AND HUMAN SERVICES, DEPARTMENT OFCENTERS FOR DISEASE CONTROL AND PREVENTIONCDC OFFICE OF ACQUISITION SERVICESATLANTA, GA, 30333, USA

NAICS

Biological Product (except Diagnostic) Manufacturing (325414)

PSC

MEDICAL- LABORATORY TESTING (Q301)

Original Source

https://sam.gov/opp/356e8ea489264dc89d205ee060ef19e6/view
Timeline
  1. 1
    Posted Aug 15, 2024, 12:00 AM UTC
  2. 2
    Updated Sep 11, 2024, 12:00 AM UTC
  3. 3
    Due Sep 16, 2024, 7:00 PM UTC
Description

The Department of Health and Human Services, specifically the Centers for Disease Control and Prevention (CDC), is seeking qualified contractors to provide rapid custom genetic products for the development of Candidate Vaccine Viruses (CVVs) against pandemic potential. The procurement includes single-stranded DNA oligonucleotides and double-stranded DNA gene fragments, with specific requirements for turnaround times, expected yields, and shipping arrangements to ensure timely delivery of these critical genetic materials. This initiative is vital for enhancing the nation's preparedness for future pandemics, emphasizing the need for flexibility in production to adapt to rapidly changing influenza strains. Interested vendors must submit their quotes by September 16, 2024, and can contact Timothy Joyce at xvf7@cdc.gov for further information.

Point(s) of Contact
Timothy Joyce
xvf7@cdc.gov
Files
Title
Posted
A19. RFQ 75D301-24-Q-78627 Amended.doc
Sep 11, 2024, 1:53 PM UTC
The Centers for Disease Control and Prevention (CDC) issued a Request for Quotations (RFQ) for the procurement of rapid custom genetic products to develop Candidate Vaccine Viruses (CVVs) against pandemic potential. The RFQ outlines the requirement for single-stranded DNA oligonucleotides and double-stranded DNA gene fragments, detailing quantities, expected yields, turnaround times, and shipping arrangements. Suppliers must provide pricing for a maximum total quantity to be delivered over a one-year performance period, with monthly invoicing based on actual usage. The importance of these genetic products is underscored by the need for flexibility in production to address rapid changes in circulating influenza strains. Key documents within the RFQ include statements of work, evaluation factors, instructions to offerors, and contract clauses. The document emphasizes adherence to federal regulations, including accessibility standards and the importance of securing sensitive data. Vendor qualifications focus on proven capacity for timely delivery of genetic material, aligning with the CDC’s ongoing need to respond swiftly to public health threats. Overall, this RFQ underlines the CDC's commitment to enhancing the nation's preparedness for future pandemics through a streamlined procurement process for essential genetic resources.
A19. RFQ 75D301-24-Q-78627 Final.doc
Sep 10, 2024, 7:32 PM UTC
The file details a Request for Quotations (RFQ) from the Centers for Disease Control and Prevention (CDC), specifically for rapid genetic material production to support the development of Candidate Vaccine Viruses (CVVs). The RFQ outlines the need for services including custom DNA oligonucleotides and double-stranded DNA gene fragments, emphasizing rapid turnaround times for samples ranging from 15 to over 2,200 base pairs in length. The work primarily aims to address the need for frequent production of genetic materials due to evolving influenza strains. The contract specifies quantities, pricing structures, and delivery timelines. Invoicing will occur monthly based on actual usage, with a performance period anticipated to last one year. Security protocols ensure no sensitive information leaves the government’s control, and vendors must meet qualifications related to production capacity and delivery speed. Compliance with Section 508 for accessibility is also mandated. This RFQ emphasizes the government's proactive approach to managing public health threats through vaccine development, fostering collaboration with capable contractors to enhance vaccine preparedness.
Lifecycle
Title
Type
Oligo CVV Production
Currently viewing
Solicitation
Similar Opportunities
Custom Labels Requirement
Buyer not available
The Department of Health and Human Services, specifically the Centers for Disease Control and Prevention (CDC), is seeking to procure custom labeling materials through a sole-source contract with Multisystems Inc. This procurement involves specialized RM 66171 Clear PolyPro labels and Thermal Transfer Ribbon Wax/Resin, which are essential for labeling specimen tubes that must endure extremely low temperatures. The labels are critical for the CDC's dengue research specimen handling and must meet specific requirements, including compatibility with the ZT 230 Printer and compliance with CLIA regulations. Interested parties are encouraged to express their capability to fulfill these requirements by April 4, 2025, and should contact Ashley Williams at dal3@cdc.gov or Sheena Delaine at kpz5@cdc.gov for further information.
CDC DFWED NARST Sensititre Supplies
Buyer not available
The Centers for Disease Control and Prevention (CDC) is seeking to award a sole source contract for antimicrobial resistance testing supplies, specifically Sensititre™ broth microdilution testing products, from ThermoFisher Scientific. This procurement is essential for the National Antimicrobial Resistance Monitoring System (NARMS), which has utilized these proprietary materials since 1996 to ensure a standardized approach to monitoring enteric bacteria resistance. The unique nature of these supplies necessitates this sole source approach, as alternatives would require significant investments in new equipment and validation processes, potentially disrupting critical surveillance efforts. Interested parties may respond within 15 days to express their interest, with proposals directed to contract specialist Ashley Williams at dal3@cdc.gov.
Notice of Intent to Sole Source - University of Michigan - Vaccine Cost-Effectiveness Models
Buyer not available
The Centers for Disease Control and Prevention (CDC) intends to award a sole source firm fixed price contract to the University of Michigan for access to proprietary models that assess the cost-effectiveness of vaccines. This procurement aims to secure detailed reports based on these models, which are deemed essential for the CDC's vaccine evaluation efforts, as no other models are known to provide the required level of detail. The contract will cover a base year with four additional option years, and interested parties may express their interest or capability to respond within fifteen days of this notice. Responses should be directed to contract specialists William O’Bryan at rvq0@cdc.gov and Ruben Reyes-Colon at qmz3@cdc.gov by 3:00 PM EDT on April 11, 2025.
Notice of Intent for RNA Oligos Biological Reagents
Buyer not available
The Department of Health and Human Services, specifically the National Institutes of Health (NIH) through its National Institute of Allergy and Infectious Diseases (NIAID), has issued a Notice of Intent for a sole-source procurement from Integrated DNA Technologies Inc. The procurement involves negotiating for 25 units of A-tag TSO primer 1 umole RNA oligo, along with associated shipping and handling costs. These reagents are critical for in-vitro diagnostic applications, supporting the NIH's ongoing research and development efforts in infectious diseases. Interested vendors are invited to submit capability statements via the NIAID electronic Simplified Acquisition Submission System (eSASS) by April 4, 2025, at 1:00 PM, with all submissions being considered by the Government at its discretion. For further inquiries, contact Leah Hinson at leah.hinson@nih.gov.
Shared Space and Support Services, San Diego
Buyer not available
The Department of Health and Human Services, specifically the Centers for Disease Control and Prevention (CDC), intends to award a sole source firm fixed price contract to the County of San Diego for shared use of a facility and support services for the US/Mexico Unit and San Diego Quarantine Station. The contract will cover essential services such as installation and maintenance of communication systems, computer support, and building services, which are crucial for facilitating in-person collaboration between CDC staff and the County's Public Health Department. This collaboration is vital to the CDC's mission, with the contract period set from September 1, 2025, to August 31, 2026, and options for two additional one-year extensions. Interested parties should submit their responses to the contract specialist, Taylor Wellman, at xur0@cdc.gov by 5:00 PM (ET) on April 4, 2025.
6550--Lab Testing Services - (HIV/HCV/HPV/On)
Buyer not available
The Department of Veterans Affairs is seeking to negotiate a sole-source contract with Roche Diagnostics Corporation for lab testing services related to HIV, HCV, and HPV at the Corporal Michael J. Crescenz VA Medical Center. The contractor will be responsible for providing FDA-approved laboratory systems, instruments, maintenance, and consumables necessary for clinical testing, including a fully automated PCR testing platform with advanced features for real-time detection and minimal maintenance. This procurement is crucial for ensuring the delivery of quality healthcare services to veterans through efficient laboratory solutions. Interested parties must express their interest or submit capabilities by February 13, 2025, and can contact Contract Specialist Yazmin Alvarez at yazmin.alvarez@va.gov or 302-944-2511 x5202 for further information.
Notice of Intent to Sole Source - Optimoz Inc
Buyer not available
The Department of Health and Human Services, specifically the Centers for Disease Control and Prevention (CDC), intends to negotiate a sole source contract with Optimoz Inc. for operations and maintenance support services related to the Virgin Islands’ Immunization Information System (IIS). This procurement aims to enhance the functionality and operational efficiency of IISs, which are critical for assessing vaccination rates and managing public health interventions to prevent vaccine-preventable diseases. The contract is justified under FAR 6.302-1, as Optimoz Inc. is the only vendor capable of providing these services without causing disruption or inefficiency in the existing IIS framework. Interested parties may submit capability statements or proposals to Matthew Nelson at mnelson2@cdc.gov by April 11, 2025, at 4:30 PM EST for consideration.
6640--FY 25 Short Term Emergency Contract Molecular Random Access Analyzer
Buyer not available
The Department of Veterans Affairs intends to award a sole-source contract to Cepheid for a Short Term Emergency procurement of a Molecular Random Access Analyzer, specifically the Cepheid GeneXpert Infinity Reagents and Consumables. This procurement is conducted under FAR 13.5 Simplified Procedures for Certain Commercial Items, emphasizing the need for efficient acquisition of critical laboratory equipment. The selected vendor must demonstrate technical capability to meet the government's requirements, with responses due by January 17, 2025, at 2:00 PM Eastern Time. Interested parties should submit their technical packages to Contract Specialist Darrin Alexander at darrin.alexander2@va.gov, noting that the government will not compensate for the information provided.
NIAID Virology Quality Assurance
Buyer not available
The National Institute of Allergy and Infectious Diseases (NIAID) is soliciting proposals for the Virology Quality Assurance (VQA) program under RFP number 75N93024R00030, aimed at enhancing quality assessment for virologic testing in clinical trials related to HIV and other viral pathogens. The program requires contractors to provide comprehensive quality assurance services, including performance validation reports and progress updates, while adhering to strict federal regulations and ethical standards concerning human subjects in research. This initiative is critical for establishing robust quality controls in virology testing, thereby supporting public health responses and ongoing research efforts. Proposals are due by April 8, 2025, at 3:00 PM EST, and interested parties should direct inquiries to Shawnice Williams at shawnice.williams@nih.gov or Ashley Kinderdine at ashley.kinderdine@nih.gov for further clarification.
Purchase of Lab Supplies
Buyer not available
The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking qualified vendors to provide various lab supplies, including cleaning and sanitation products, under solicitation number 75N98025Q00021. The procurement aims to ensure the NIH is equipped with essential supplies such as paper towels, disinfectant wipes, and hand soap, which are critical for maintaining hygiene and safety in healthcare environments. This opportunity includes a partial small business set-aside, encouraging participation from small businesses, including service-disabled veteran-owned and women-owned enterprises, with a focus on timely delivery within a 10-day timeframe. Interested vendors must submit their quotes via email by 4:30 PM Eastern Daylight Time on April 9, 2025, and can direct inquiries to Carol Hayden at haydenc@od.nih.gov.